Richard Lindstrom is an Ophthalmology physician affiliated with Minnesota Eye Consultants. OpenAlex indexes 29 publications with 218 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9801 Dupont Ave S
Suite 200
Bloomington, MN 554313100
Telephone
952-888-5800Registry record last updated 25 Mar 2013.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20254 payments$541,910openpaymentsdata.cms.gov ↗
- Ocular Therapeutix, Inc.Program year20257 payments$395,697openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year20258 payments$10,319openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Prostaglandin Analog100%Latanoprost100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1989 per NIH RePORTER. The latest:
- PROSPECTIVE EVALUATION OF RADIAL KERATOTOMY (PERK)
University of Minnesota Twin Cities
FY1988U01EY003767 - PROSPECTIVE EVALUATION OF RADIAL KERATOTOMY (PERK)
University of Minnesota Twin Cities
FY1987U01EY003767
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye
Journal of Cataract & Refractive Surgery
2024 - Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication
Dove Medical Press (Taylor and Francis Group)
2020 - Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication
DOAJ (DOAJ: Directory of Open Access Journals)
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Jacob Brubaker, MD
Minnesota Eye Consultants
Sara Haug, MD, PhD
Minnesota Eye Consultants
Allan Hunter, MD
Minnesota Eye Consultants
Peter Karth, MD
Minnesota Eye Consultants
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”